Intakes of Alcohol and Folate During Adolescence and Risk of Proliferative Benign Breast Disease
WHAT'S KNOWN ON THIS SUBJECT: Alcohol consumption during adolescence and early adulthood has been associated with an increased risk of biopsy-confirmed benign breast disease (BBD), an established risk factor of breast cancer.
WHAT THIS STUDY ADDS:
This is the first study to analyze the association between adolescent alcohol consumption and risk of biopsy-confirmed proliferative BBD by adolescent folate intake. The result provides no evidence for protective effects of adolescent folate intake on risk of alcohol-associated BBD. abstract OBJECTIVES: To examine the combined effect of alcohol and folate intake during adolescence on the risk of proliferative benign breast disease (BBD).
METHODS:
We used data from 29 117 women in the Nurses' Health Study II who completed both adolescent alcohol consumption questions in 1989 and an adolescent diet questionnaire in 1998. A total of 659 women with proliferative BBD diagnosed between 1991 and 2001 were confirmed by central pathology review. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals (CIs), adjusted for established risk factors of breast cancer.
RESULTS: Adolescent alcohol consumption was dose-dependently associated with an increased risk of proliferative BBD (hazard ratio = 1.15 per 10 g/day consumption; 95% CI, 1.03-1.28). There was no significant association between adolescent folate intake and the risk of proliferative BBD. Stratified analyses showed that each 10-g/day alcohol intake during adolescence was associated with a 21% (95% CI, 1.01-1.45) increase in the risk of proliferative BBD among women with low folate intake during adolescence, which was not significantly different from the alcohol-associated risk among women with moderate and high folate intake during adolescence (P for interaction = 0.18).
CONCLUSIONS: Adolescent alcohol consumption is associated with increased risk of proliferative BBD, which may not be reduced by increased folate intake during adolescence. Pediatrics 2012;129: e1192-e1198 AUTHORS: Ying Liu, MD, PhD, a Rulla M. Tamimi, ScD,
Alcohol is an established risk factor for breast cancer; a 10-g/day increment in consumption by adult women is associated with a 7% to 10% increase in breast cancer risk. [1] [2] [3] However, the mechanism(s) underlying this association remains unclear. One potential mechanism relates to the impact of alcohol on folate metabolism; alcohol may hinder the bioavailability of dietary folate, 4 particularly in heavy drinkers. 5 Folate deficiency leads to aberrations in synthesis, repair, and methylation patterns of DNA. 6 Although a meta-analysis did not support the protective effect of folate intake on breast cancer risk, 7 a significant interaction between alcohol and folate intake has been reported for breast cancer. [8] [9] [10] [11] [12] [13] Given that proliferative benign breast disease (BBD) is associated with risk of subsequent invasive breast cancer, 14, 15 the associations between intakes of alcohol and folate and the risk of proliferative BBD could have implications for the prevention of breast cancer. The results of epidemiologic studies of alcohol consumption and proliferative BBD have been inconsistent or even conflicting. [16] [17] [18] [19] [20] In a cohort of postmenopausal women, folate intake was not associated with the risk of proliferative BBD. 17 One possible explanation for the null findings is that these studies did not focus on an etiologically relevant exposure period. 21 The mammary glands may be most vulnerable to carcinogenic influences during the time between menarche and first childbirth because breast tissue undergoes rapid cellular proliferation during adolescence and terminal differentiation occurs during first pregnancy. 22 In support of this hypothesis, the Nurses' Health Study II (NHSII) found that the risk of proliferative BBD was similar in women with recent (adult) intake of 15+ g/day of alcohol and in nondrinkers but was positively associated with alcohol consumption at ages of 18 to 22 years. 16 Using data from the NHSII, we updated and expanded on these findings by testing the hypotheses that adequate folate intake during adolescence would reduce the risk of proliferative BBD associated with alcohol consumption between ages 18 and 22 years, and that a protective effect of adolescent folate intake on risk of proliferative BBD would be limited to women with higher alcohol consumption between ages 18 and 22 years.
METHODS

Study Population
The 16 Total alcohol consumption was expressed in grams of ethanol per day. The report of adolescent alcohol consumption has been shown to be valid in the NHSII participants. 24 
HS-FFQ
The 131-item HS-FFQ that was derived from the validated FFQ on adult diets used in the NHS and NHSII cohorts was completed in 1998 by 45 948 NHSII participants. 25 Participants were asked how often, on average, they had consumed a specified quantity of 122 foods and beverages during high school, further defined as ages of 13 to 18 years. The daily nutrient intake from a given food was calculated by multiplying its portion size by the number of servings per day and its nutrient content. The daily nutrient intake for each participant was then estimated by summing across all food items. Because the composition of some foods had changed over time, food composition data from the relevant time period (1960s and 1970s) were used, when available, to obtain the best approximation of intake during adolescence. Multivitamin use in high school was used to estimate supplemental folic acid intake at that time period. Total folate intake was estimated by summing folate consumed per day from food and supplemental sources.
Statistical Analysis
Because biopsy specimens were collected and reviewed for women who reported a first diagnosis of biopsyconfirmed BBD during the previous 2 years on the 1993-2001 questionnaires, the follow-up period for this analysis was from 1991 to 2001. Participants (n = 45 716) were eligible for the current analysis if they provided their alcohol consumption between ages 18 and 22 years, returned the HS-FFQ in 1998, and had reasonable values for total energy intake (a range of 600-5000 kcal/day) in high school. Participants (n = 16 378) were excluded from the analysis if they reported a previous history of BBD (n = 15 990) or cancer other than nonmelanoma skin cancer (n = 370) on the 1989 and 1991 questionnaires or if their biopsy date was before the return date of the 1991 questionnaire (n = 18). Additionally, we excluded 221 women from the analysis because they were identified to have statistical outlier values on the high end of alcohol distribution using the generalized extreme studentized deviate many-outlier detection approach. 26 The results were similar when these 221 (0.7% of eligible women) were included in the analysis.
Here we reported the analysis including 29 117 women.
Alcohol consumption between ages 18 and 22 years was categorized into 4 groups: no consumption (none), any consumption up to 5 g of ethanol/day (0.1-4.9 g/day), between 5 and 15 g/day (5.0-14.9 g/day), and 15+ g/day. Total and dietary folate intakes during adolescence were adjusted for energy intake using the residual method 27 and were then categorized into tertiles based on the distributions of intake among all eligible women.
Cox proportional hazards models were used to compute hazard ratios (HRs) and 95% confidence intervals (CIs), which were used as estimates for relative risks ( Over an average of 10 years of follow-up, 659 incident cases of proliferative BBD were identified, including 59 with atypia and 600 without atypia. We next examined the combined effect of alcohol and folate intake during adolescence on the RR of proliferative BBD (Table 3) . Among women with low total folate intake, moderate alcohol consumption was related to a 67% increased risk (95% CI, 1.17-2.39) and high alcohol consumption was related to a The model adjusted for age in months, total energy intake (quintiles), age at menarche (,12, 12, 13, or $14 y), menopausal status (premenopausal, postmenopausal, or uncertain), average body size between ages 5 and 10 y (somatotype pictogram 1, 1.5-2, 2.5-3, 3.5-4.5, or $5), family history of breast cancer in mother or sister(s) (yes versus no), recency and duration of oral contraceptive (OC) use (never, past ,4 y, past $4 y, current ,4 y, or current $4 y), current alcohol consumption (none, 0.1-4.9 g/day, 5.0-14.9 g/day, 15+ g/day, or missing), and parity and age at first birth (nulliparous; 1-2 pregnancies, age at first birth ,25 y; 1-2 pregnancies, age at first birth 25-29 y; 1-2 pregnancies, age at first birth $30 y; $3 pregnancies, age at first birth ,25 y; $3 pregnancies, age at first birth 25-29 y; or $3 pregnancies, age at first birth $30 y).
a 57% increased risk (95% CI, 0.97-2.56). There was no evidence that increased folate intake significantly reduced the excess risk of proliferative BBD associated with higher alcohol consumption; a 10-g increase in daily alcohol consumption was associated with a 21% increased risk (95% CI, 1.01-1.45) among women with low total folate intake, a 15% increased risk (95% CI, 0.95-1.38) among women with moderate total folate intake, and a 13% increased risk (95% CI, 0.92-1.40) among women with high total folate intake. The interaction between alcohol and total folate intake was not statistically significant (P = .18). There was no interaction between alcohol and dietary folate intake in proliferative BBD (data not shown).
DISCUSSION
This analysis revealed that the risk of proliferative BBD increased by 15% for each 10 g of alcohol consumed per day at the ages of 18-22 years and did not differ significantly across tertiles of total folate intake in high school.
To date, 6 epidemiologic studies have examined alcohol consumption as a risk factor for proliferative BBD, with inconsistent results. [16] [17] [18] [19] [20] 29 Neither recent nor lifetime alcohol consumption was associated with the risk of proliferative BBD in 2 case-control studies 18, 19 and a cohort study of postmenopausal women. 17 During the 6-year follow-up, the NHSII participants with recent (adult) intake of 15+ g/day of alcohol had similar risk of biopsy-confirmed proliferative BBD as nondrinkers; however, the risk was positively associated with alcohol consumed between ages 18 and 22 years. 16 A prospective assessment of alcohol consumption in daughters of NHSII participants also showed that alcohol consumption between ages 16 and 22 years was associated with a 50% (odds ratio, 1.50 per drink per day; 95% CI, 1.19-1.90) increased risk of overall BBD (including both proliferative and nonproliferative BBD [not confirmed by central pathology review]). 29 Taken together, these findings suggest that alcohol consumption during adolescence and early adulthood may have more impact on the early stages of breast tumor progression than consumption of alcohol later in life.
We further analyzed the combined effect of alcohol consumption at the ages of 18-22 years and folate intake in high school on proliferative BBD. To the best of our knowledge, this is the first study to examine the modifying effect of adolescent folate intake on the association between alcohol consumption during adolescence and early adulthood and proliferative BBD. Our study did not support the hypothesized interaction between adolescent alcohol and folate intake in proliferative BBD; although among women with low folate intake, risk of proliferative BBD increased with higher alcohol consumption, increased folate intake did not significantly reduce the risk associated with high alcohol consumption. The null finding was consistent with the Women' s Health Initiative randomized clinical trials that provided no evidence for the interaction between recent (adult) alcohol and 18. a The model adjusted for age in months, total energy intake (quintiles), age at menarche (,12, 12, 13, or $14 y), menopausal status (premenopausal, postmenopausal, or uncertain), average body size between ages 5 and 10 y (somatotype pictogram 1, 1.5-2, 2.5-3, 3.5-4.5, or $5), family history of breast cancer in mother or sister(s) (yes versus no), recency and duration of oral contraceptive (OC) use (never, past ,4 y, past $4 y, current ,4 y, or current $4 y), current alcohol consumption (none, 0.1-4.9 g/day, 5.0-14.9 g/day, 15+ g/day, or missing), and parity and age at first birth (nulliparous; 1-2 pregnancies, age at first birth ,25 y; 1-2 pregnancies, age at first birth 25-29 y; 1-2 pregnancies, age at first birth $30 y; $3 pregnancies, age at first birth ,25 y; $3 pregnancies, age at first birth 25-29 y; or $3 pregnancies, age at first birth $30 y.
folate intake in the risk of proliferative BBD. 17 In addition, 3 cohort studies reported that the risk of invasive breast cancer associated with recent alcohol consumption did not significantly vary with recent folate intake, [30] [31] [32] although 8 cohort studies showed stronger positive associations between recent alcohol consumption and the risk of invasive breast cancer in women who had low folate intake or circulating folate concentrations versus women with high folate intake or circulating folate concentrations. [8] [9] [10] [11] [12] [13] 33 Despite the critical role of folate in gene expression and DNA repair, the reported relationship between folate intake or circulating folate levels and breast cancer risk has been inconsistent. 7 Our study provides no evidence for a protective effect of folate intake during adolescence on risk of proliferative BBD. Among adult women with recent alcohol consumption 15+ g/day, consumption of $600 mg of total folate per day was associated with a 44% (RR = 0.56, 95% CI, 0.41-0.79) decreased risk of invasive breast cancer in comparison with consumption of 150-299 mg of total folate/ day. 13 Therefore, our null finding could be due to the average level of total folate intake (median = 310 mg/day) in our sample that was too low to detect a significantly inverse association with risk of proliferative BBD.
The primary limitation of this study concerns the reliability of recalled alcohol and folate intake during adolescence.
In the NHSII participants, recall of adolescent diet occurred an average of 25 years later. However, the HS-FFQ has been demonstrated in the NHSII participants to have moderate 4-year reproducibility (folate intraclass correlation coefficient = 0.72) and to be independent of adult diet. 24 Furthermore, the HS-FFQ was compared with 24-hour recalls in NHSII offspring; the FFQ collected when the participants were in high school showed moderate correlations. 34 Therefore, the HS-FFQ provides a reasonable record of adolescent diet. In addition, the moderately high correlation between folate intake from the first HS-FFQ and from the second HS-FFQ (4 years later) suggested that use of folate intake collected 9 years after collection of adolescent alcohol intake should have little impact on the current analysis. Further, differential recall bias should be minimal because women with proliferative BBD in our study had no previous cancer diagnosis, although some reported their folate intake in high school after being diagnosed with BBD. The current analysis focused on alcohol consumption at ages 18 to 22 years, which is later than folate intake in high school. In our sample, folate intake is unlikely to have changed substantially between adolescence and early adulthood because folate fortification in the United States was not introduced until 1998. 35, 36 However, we cannot evaluate how much individuals modified their own diets after high school; folate intake during the same time period as alcohol consumption may be more relevant, and our use of high school folate intake may underestimate this association.
Proliferative BBD is histologically divided into 2 groups based on the presence of atypia. Atypical hyperplasia confers higher risk of subsequent breast cancer than hyperplasia without atypia. 14, 15, 37, 38 Due to the very small number of cases with atypia in the current analysis, we were unable to address whether alcohol consumption during adolescence is differentially associated with proliferative BBD with and without atypia.
CONCLUSIONS
This study suggests a dose-dependent increase in risk of proliferative BBD with alcohol consumption during adolescence and early adulthood, which may not be reduced through increased folate intake. This result, if confirmed in studies performed in other populations, indicates that increased folate intake during adolescence may not effectively prevent alcohol-associated breast cancer. Since alcohol use is common in adolescent girls and young women, 39, 40 reducing alcohol consumption during adolescence and early adulthood is currently the only dietary strategy that may reduce risk of proliferative BBD.
